Le Lézard
Classified in: Health

Lucio Gordan, MD Serves on Panel of Oncology Leaders Sharing Insights with Oncology Fellows


FORT MYERS, Fla., April 26, 2024 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) President & Managing Physician Lucio N. Gordan, MD will serve as a panelist at the 2024 Oncology Fellows & Faculty Forum in Miami, sponsored by PrecisCa and the Community Oncology Alliance (COA). Dr. Gordan will participate with oncology physician executives for the Oncology Leaders in Business and Practice panel discussion.

"I consider it a great privilege to spend time with these young physicians as they prepare to launch their medical careers," Dr. Gordan said. "In this dynamic setting, my colleagues and I will share real-world experiences encompassing the many unique and often complex facets of the oncology field beyond clinical practice."

The exclusive three-day gathering provides oncology professionals with opportunities to interact with the world's oncology experts. Through networking sessions and panel discussions they gain insights into the latest advancements and breakthroughs in oncology research and treatment and guidance to enhance their leadership skills and business acumen.

PrecisCa provides patients and providers with access to world-class cancer experts to enhance the quality of cancer, including a range of content offerings, educational opportunities and peer-to-peer mentorship to develop oncology's future emerging leaders. The Community Oncology Alliance (COA) is a non-profit organization solely dedicated to advocating for community oncology practices and the patients they serve.

About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)

Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. The majority of new cancer drugs recently approved for use in the U.S. were studied in clinical trials with FCS participation.* Recognized for our research, FCS is a recipient of the national Clinical Trials Participation Award presented by the American Society of Clinical Oncology (ASCO). FCS physicians, trained in prestigious medical schools and research institutes, are consistently ranked nationally as Top Doctors by U.S. News & World Report.

Celebrating its 40th year in 2024, FCS has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies and advanced treatments, including targeted therapies genomic-based treatment and immunotherapy. Our highest values are embodied by our outstanding team of highly trained and dedicated physicians, clinicians and staff.

*Prior to approval

SOURCE Florida Cancer Specialists & Research Institute


These press releases may also interest you

at 09:35
Seres Therapeutics, Inc. , a leading microbiome therapeutics company, today announced that management will host a conference call and live audio webcast on May 8, 2024 at 8:30 a.m. ET to discuss first quarter 2024 financial results and provide...

at 09:30
The Prime Minister, Justin Trudeau, today issued the following statement on National Nursing Week, which runs from May 6 to 12: "Today, as we mark the start of National Nursing week, I join Canadians across the country to celebrate our nurses, their...

at 09:30
CG Pharmaceuticals, a late-stage clinical biopharmaceutical company specializing in metastatic pancreatic ductal adenocarcinoma (PDAC) maintenance therapy (NCT05249101), will feature one of our investigators, Dr. Christos Fountzilas from Roswell Park...

at 09:25
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, provides an update on the initiative to...

at 09:23
To mark mental health awareness, OOt Social Health proudly launches its app to revolutionise community engagement. OOt Social Health represents a paradigm shift in fostering vibrant communities through face-to-face interactions, blending proximity,...

at 09:21
Scinai Immunotherapeutics Ltd. , a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological products and on providing CDMO services through its Scinai Bioservices business unit, today announced that it had had...



News published on and distributed by: